Bayer Income from Continuous Operations 2010-2025 | BAYRY

Bayer income from continuous operations for the twelve months ending March 31, 2025 was $-3.555B, a 6.03% increase year-over-year.

  • Bayer annual income from continuous operations for 2024 was $-2.755B, a 13.48% decline from 2023.
  • Bayer annual income from continuous operations for 2023 was $-3.184B, a 172.54% decline from 2022.
  • Bayer annual income from continuous operations for 2022 was $4.389B, a 263.01% increase from 2021.

Bayer Income from Continuous Operations 2010-2025 | BAYRY

  • Bayer annual income from continuous operations for 2024 was $-2.755B, a 13.48% decline from 2023.
  • Bayer annual income from continuous operations for 2023 was $-3.184B, a 172.54% decline from 2022.
  • Bayer annual income from continuous operations for 2022 was $4.389B, a 263.01% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$757.6B
Johnson & Johnson (JNJ)$377.3B
AbbVie (ABBV)$338.3B
Novo Nordisk (NVO)$307.8B
Roche Holding AG (RHHBY)$256.9B
Novartis AG (NVS)$255.7B
Merck (MRK)$210.1B
Pfizer (PFE)$144.1B
Sanofi (SNY)$119.1B
Innoviva (INVA)$1.2B